Browse products
Dietary supplements market in Poland 2011Development forecasts for 2011-2013 |
Polish version also available »
Our clients say...
The report is an analysis of the current situation on the Polish market of dietary supplements, including development forecasts for 2011-2013.
“As a London-based company, with operations abroad, we looked for the best-in-class Market Intelligence supplier. PMR brought us quality reports that improved our CEE market knowledge and understanding.”
Development Manager, GVA Grimley
“PMR provides a good service and is always open to discussion. All reports are well structured & are always on time.”
Member of the Managment Board, SCA Hygiene Products
“We use PMR's services due to their analysts' extensive experience in market analysis, their high quality and level of engagement in the market research carried out for us. We consider PMR a competent and professional company and recommend them as a reliable partner in the area of economic information and market analysis.”
Senior Trade and Investment Adviser, British Embassy in Warsaw
“PMR's analysts understand our needs well and the standard of their service has always fully met our expectations. We are looking forward to cooperating with PMR in the future as well. ”
Senior Trade and Investment Adviser, British Embassy in Warsaw
“We consider PMR a competent and professional company. PMR analysts understand our needs clearly and their services have fully met our expectations. I strongly recommend the company as a reliable partner in providing economic information and market analysis.”
General Manager, Sanofi-Synthelabo
“It's a great pleasure to cooperate with PMR because of its analysts' wealth of experience in understanding the local market. We consider PMR a competent and professional company which helps us conduct our business. I would also like to state that PMR's team is always ready to respond to emerging customer needs. We can recommend it as a reliable partner.”
Business Analyst, Hilti Distribution, Russia
“Sanofi-Aventis group regularly order PMR's reports and newsletters concerning the Polish pharmaceutical market. We use PMR's services because of the wealth of experience of its analysts in undertaking market analysis and a high level of quality and involvement in the field of market research. ”
General Manager, Sanofi-Synthelabo
“PMR reports are a serious contribution to the market overview picture, focusing our attention on key events in the industry as well as highlighting both general and specific market indicators. Together, these components are the base for our future forecasts of construction market development and help us to plan our sales.
”
Market Analyst, Alpha Cement
It presents a detailed description of individual supplement groups and their growth prospects for the coming years.
The report includes profiles of the top players operating in the sector and their financial results.
It also covers the current changes in legislation and their impact on the market.
It is completed by the presentation of a unique study of 97 manufacturers and distributors of dietary supplements in Poland.
Excel database. Reliable data in a convenient format.
Did you know...
The report is accompanied by the "Database of firms on the dietary supplement market in Poland 2011". It comprises nearly 200 records and includes the following information about each firm:
“In 2010 the value of the market of dietary supplements in Poland exceeded PLN 2bn.”
“The market of dietary supplements in Poland is still undersaturated.”
“In August 2011, Laboratoria Natury was acquired by an Israeli company, Maabarot.”
“Most players on the Polish dietary supplements market expect that their financial condition is going to improve in 2011.”
“As of January 2010, borderline products present on the market have to be registered as medicines.”
“Polish consumers believe that vitamins and minerals are the crucial components of a healthy diet.”
“The grocery chain Spolem is planning to launch private label parapharmaceuticals and dietary supplements.”
- full and abbreviated name
- form of activity (e.g. producer, distributor etc.)
- address
- telephone and fax
- website
- key products (dietary supplements).
Key issues:
- development forecasts for 2011-2013
- pharmacy and non-pharmacy segments of the market of dietary supplements in Poland – market shares, financial results, development of dietary supplement portfolios in the recent years
- an analysis of the growth potential for each category of dietary supplements, as well as consumer trends and epidemiological data of crucial importance for the individual categories
- the procedure of introducing a dietary supplement onto the Polish market
- changes in the health and nutrition statements
- changes in the composition of dietary supplements
- changes introduced by the law on food and nutrition safety
- an analysis of the channels of dietary supplement distribution
- growth opportunities and barriers on the Polish dietary supplement market
- an assessment of the dietary supplement notification process for firms active on the marketmarket condition of the firms trading in dietary supplements in Poland.
Questions the report answers:
- How will the Polish market of dietary supplements develop over the next three years?
- Which categories have the biggest potential on the market?
- What are the key producers of dietary supplements in Poland?
- Which firms have been developing their portfolio of dietary supplements with the greatest intensity over the last years?
- What changes in health statements have been planned on the market?
- What nutrition statements can be applied to dietary supplements?
- What changes for the dietary supplement segment have been introduced by the law on food and nutrition safety?
- What vitamins and minerals, and in what form, can be used for the production of dietary supplements in Poland?
- How do firms present on the Polish dietary supplement market rate its growth prospects?
- What are the main growth barriers for the firms operating on the market if dietary supplements in Poland?
- What is the average duration time for the process of introducing a dietary supplement on the market in Poland?
- What is the financial condition of the firms present on the Polish dietary supplement market?
Strong points of our report:
- a unique survey conducted in 2011 among nearly 100 firms – a comparison of current findings with the findings from 2007 – interesting conclusions concerning the changes on the market
- development forecasts for the market for 2011-2013
- third edition of the report equips you with a wide range of historical data
- Excel base with contact data and product offer of firms operating on the Polish market of dietary supplements
- interesting complement to other reports: Non-pharmacy OTC 2011, OTC in CEE 2011, or OTC in PL 2010.
In what business situations will the study be most useful?
- starting business on dietary supplements market in Poland
- developing dietary supplements portfolio in Poland
- analyzing main competitors
- monitoring legal changes
- preparing forecasts about dietary supplements market in Poland
This report is highly recommended to:
- manufacturers and distributors of dietary supplements in Poland
- companies that would like to invest in the segment (e.g. through acquisitions)
- consulting, research and analysis firms
- government institutions, embassies, universities and research institutes
- chambers of commerce, trade and industry organisations
- financial institutions (banks, brokerage houses, investment funds
Extract from this report
- In 2009 the Chief Sanitary Inspectorate (GIS) received a record-breaking 1,900 notifications of the first marketing of dietary supplements. In 2007-2008 the figure was around 700 each year, and in 2010 reached over 900.
- At the moment the biggest growth barrier for companies is a long and complicated procedure of notifications at the Chief Sanitary Inspectorate (17%). The percentage of respondents who indicated this barrier has not changed over the past four years.
Market commentary by expert
According to our forecasts, between 2011 and 2013 the Polish market of dietary supplements is going to expand at the rate of 9-15% a year. Although the market dynamic will be lower than in 2006-2008, it is worth noting that it is still high, and higher than in the case of e.g. OTC medicines. We expect that the trends that appeared in the previous years and had a positive impact on sales are going to continue, such as the ageing of the population, increased interest in self-treatment, in healthy lifestyle and healthy appearance, as well as natural and herbal products.Agnieszka Sokonieczna and Monika Stefańczyk, Pharmaceutical market analysts
Request sample pages/interactive screenshare
-
Report methodology p. 11
-
Executive summary p. 15
-
Overview of the dietary supplements market in Poland p. 19
- Key events and trends p. 19
- Size of the dietary supplements market in 2005-2013 p. 24
-
Percentage shares of the individual distribution channels in total market value p. 25
- Pharmacy distribution p. 26
-
Non-pharmacy distribution p. 26
- Market value and development forecasts p. 26
- Overview of the segment in hypermarkets p. 27
-
Online sales p. 30
- Market value and development forecasts p. 30
- Most popular categories of dietary supplements sold online p. 31
- Dietary supplement market in comparison with other pharmaceutical segments p. 32
-
Analysis of individual categories of dietary supplements p. 35
- Preferred health-related diet components p. 35
-
Individual categories: key characteristics and assessment of development potential p. 36
- Vitamins and minerals p. 38
- Gastric products p. 39
- Eye health supplements p. 41
- Cold and flu products p. 42
- Omega-3 and omega-6 fatty acids products p. 43
- Preparations supporting the nervous system p. 44
- Preparations supporting joints and muscles p. 45
- Preparations regulating alcohol metabolism p. 47
- Preparations enhancing memory and concentration p. 48
- Libido enhancing preparations p. 48
-
Results of a survey conducted among companies engaged in the dietary supplements trade in Poland p. 49
- Introduction p. 49
-
Assessment of the situation on the dietary supplements market p. 50
- Assessment of the current market situation p. 50
- Development forecasts for the market in 2012 p. 51
-
Dietary supplements market trends in 2012 p. 54
- OTC-supplement switches – prospects and development trends p. 54
- Mergers and acquisitions foreseen for 2012 p. 57
- Possible emergence of new market players p. 58
-
Opportunities and challenges to development of operations on the dietary supplements market in Poland p. 58
- Key barriers to development of operations p. 58
- Key factors conducive to development of operations p. 60
-
Dietary supplements notification process p. 63
- Assessment of GIS’ activities p. 63
-
Explanatory proceedings p. 64
- Frequency of explanatory proceedings p. 64
- Explanatory proceedings and product launch p. 66
- Subject matter of explanatory proceedings p. 67
- Time required to register a dietary supplement in Poland p. 68
-
Business profiles and current market situation of companies engaged in dietary supplements trade in Poland in 2010 and 2011 p. 69
- Impact of borderline products provisions on companies p. 69
-
Financial standing p. 70
- 2010 p. 70
- 2011 p. 72
- Foreign investors’ impact on the Polish dietary supplements market p. 73
- Workforce p. 74
- Year of commencement of operations in Poland p. 75
- Number of dietary supplements in assortment p. 76
- Country of origin of raw materials p. 76
-
Key players on the dietary supplements market in Poland p. 77
- Selected players’ business profiles p. 78
-
Legal environment p. 97
- Legislation governing the dietary supplements market in Poland p. 97
- Institutions regulating the market p. 98
- Definition p. 98
- Marketing dietary supplements p. 99
- Safety p. 101
- Labelling p. 101
- Advertising p. 102
- Health and nutrition claims p. 102
- Composition p. 106
- Changes regarding dietary supplements under amendment to the Act on Safety of Food and Nutrition p. 109
-
Distribution of dietary supplements in Poland p. 111
- Wholesale distribution p. 111
- Distribution in pharmacies and pharmacy points p. 112
- Online distribution p. 114
- Non-pharmacy distribution p. 114
-
Macroeconomic trends p. 115
- GDP p. 115
- Employment p. 116
- Wages p. 117
- Inflation p. 118
- Income and spending of households p. 118
-
Demographic trends p. 121
- Population and natural increase p. 121
- Aging population p. 122
- Life expectancy p. 124
- Sex structure of the population p. 125
- Urbanisation process p. 125
-
List of graphs p. 127
-
List of tables p. 131
-
About PMR p. 133
-
Contact PMR p. 134
List of graphs
- Structure of the surveyed sample, by company type, 2011 12
- Structure of the surveyed sample by position held, 2011 13
- Value (PLN m) and growth of the dietary supplements market in Poland, 2005-2013 16
- Number of dietary supplements in Poland of whose launch the GIS was notified, 2007-2010 and January-February 2011 20
- Value (PLN m) and change in the dietary supplement market in Poland, 2005-2013 25
- Percentage shares of individual distribution channels in the dietary supplements market in Poland, 2010 25
- Assessment of development prospects of non-pharmacy channels for dietary supplements distribution for the next year in Poland, 2011 26
- Most popular dietary supplements sold in hypermarkets in Poland, July 2011 28
- Shares of individual therapeutic categories of dietary supplements in the number of products in hypermarkets in Poland, 2011 28
- Assessment of development prospects for online distribution of dietary supplements in Poland, 2011 30
- Most popular medicines and dietary supplements sought in internet pharmacies in Poland, May 2010 31
- Bestselling product categories available from online pharmacies in Poland, 2010 32
- Dietary supplements share in the total OTC market in Poland, 2006 and 2010 32
- Comparison of sales growth in individual segments of Polish pharmacy market, 2006-2010 33
- Pharmacy sales of OTC products in Poland, by product status, 2010 33
- Non-pharmacy sales of OTC products in Poland, by product status, 2010 34
- Key components of food and beverages beneficial to health, Poland versus other countries, 2011 35
- Perceived significance of food and beverage components beneficial to health, by age, 2011 36
- Development prospects of selected groups of dietary supplements in Poland (% of respondents), 2011-2014 37
- Body weight in adult Poles, men and women, 2009 39
- Most frequent eye problems experienced by Poles working at the computer, 2011 41
- Number of new flu cases in Poland (’000), January-October 2010-2011 43
- Poles’ stress level, by sex and age, 2010 45
- Most common chronic muscle and skeletal conditions in men and women in Poland, 2009 46
- Most common muscle and skeletal ailments Poles suffer from while working at the computer, 2011 46
- Assessment of current situation on dietary supplements market in Poland, 2007 and 2011 50
- Reasons for positive assessment of dietary supplements market situation in Poland, 2007 and 2011 51
- Assessment of the situation change in dietary supplements sector in Poland next year, 2007 and 2011 52
- Reasons for positive forecasts for dietary supplements market in Poland, 2007 and 2011 53
- In the coming year, manufacturers of OTC drugs in Poland will attempt to change the status of their products to dietary supplements wherever possible, 2007 and 2011 54
- OTC drugs likely to undergo the OTC drug-dietary supplement switch in Poland, 2011 56
- Which type of dispensing category change is the most beneficial to company? (number of responses), 2010 56
- Smaller players will be acquired by bigger players in Poland next year, 2007 and 2011 57
- New significant manufacturers/distributors will enter the Polish market next year, 2007 and 2011 58
- Key barriers to companies’ development on the Polish dietary supplements market, 2007 and 2011 60
- Key stimuli for operations’ development on the Polish dietary supplements market, 2007 and 2011 61
- Assessment of the GIS’s activities related to dietary supplements trading in Poland of companies operating on the market, 2007 and 2011 63
- GIS’s reaction to company’s notification about first marketing of a dietary supplement in Poland, 2007 and 2011 65
- Percentage of dietary supplements for which explanatory proceedings were conducted in Poland, 2011 65
- Assessment of the impact the notification of the GIS of a dietary supplement in Poland has on its launch, 2007 and 2011 66
- Issues most commonly arising in GIS explanatory proceedings in Poland, 2007 and 2011 67
- Duration of the process of marketing a dietary supplement in Poland (number of days), 2007 and 2011 68
- Duration of the process of marketing a dietary supplement in Poland (number of days), 2011 68
- Assessment of product portfolio changes after borderline products provisions became effective in 2010 in Poland, September 2011 70
- Did the company’s revenue in Poland in 2010 increase, decrease or remain unaltered relative to 2009? 70
- Revenue of companies operating on the dietary supplements market in Poland, 2010 71
- Percentage of revenue generated by dietary supplements sales in companies operating on the studied market in Poland, 2010 72
- Assessment of the current financial situation of companies operating on the dietary supplements market in Poland relative to the previous year, 2011 72
- Financial situation forecast for 2011 for companies operating on the dietary supplements market in Poland, 2007 and 2011 73
- Polish and foreign companies on the dietary supplements market in Poland, 2007 and 2011 74
- Headcount in companies operating on the dietary supplements market in Poland, 2011 75
- Year of market entry of companies operating on the dietary supplements market in Poland 75
- Number of dietary supplements in assortment of companies in Poland (% of firms), September 2011 76
- Estimate market shares of selected biggest dietary supplements manufacturers in Poland, 2010 77
- Shares of dietary supplement manufacturers in the number of products in hypermarkets in Poland, July 2011 78
- Aflofarm Fabryka Lekow sales revenues and net profit (PLN m), 2005-2009 80
- Aflofarm Farmacja Polska sales revenues and net profit (PLN m), 2005-2009 80
- Revenue (PLN m) and change for Bayer in Poland, 2006-Q1 2011 81
- Boehringer Ingelheim’s revenue and net profit in Poland (PLN m), 2008-2009 82
- GlaxoSmithKline Consumer Healthcare’s revenue and net profit/loss in Poland (PLN m), 2001-2010 84
- Merck’s revenue and net profit in Poland (PLN m), 2006-2010 85
- NP Pharma’s revenue and net profit in Poland (PLN m), 2008-2009 87
- Natur Produkt Zdrovit’s revenue and net profit in Poland (PLN m), 2008-2009 88
- Kruger Polska’s revenue and net profit in Poland (PLN m), 2008-2009 88
- Revenue (PLN m) and change for Polski Lek, 2006-2010 91
- Revenue (PLN m) and change for US Pharmacia, 2009-2010 94
- Walmark’s revenue and net profit in Poland (PLN m), 2008-2009 96
- Procedure for marketing of dietary supplements in Poland, 2011 100
- Market shares of the biggest pharmaceutical wholesalers in Poland, sales to pharmacies, H1 2011 112
- Selected biggest pharmacy chains in Poland, by number of stores, October 2011 113
- GDP real growth rate in Poland (%), 2000-2013 116
- Unemployment rate in Poland (%), 2007-2013 117
- Average gross monthly salary in the national economy in Poland (PLN), 2001-2010 117
- Annual CPI in Poland (%), 2001-2013 118
- Average monthly income and spending per capita in Polish households (PLN), 2001-2010 119
- Natural increase in Poland (‘000), 1990, 1995, 2000, 2004-2010 121
- Fertility rate in Poland and selected countries, 2011 122
- Age structure of the Polish population, 2000 and 2010 123
- Forecast for the Polish population in selected age groups (m), 2010, 2015, 2020, 2025, 2030, 2035 123
- Men’s life expectancy at birth in Poland compared to selected European countries, 1990 and 2009 124
- Women’s life expectancy at birth in Poland compared to selected European countries, 1990 and 2009 124
- Poland’s inhabitants by sex, 2010 125
- Population in Poland by place of residence, 2010 125
- Percentage of urban population in Poland, by voivodship (%), 2010 126
List of tables
- Number of products and market players in selected categories of dietary supplements in hypermarkets in Poland, 2011 29
- Dietary supplements notified in Poland by Aflofarm, 2010-February 2011 81
- Dietary supplements notified in Poland by GlaxoSmithKline, 2010-February 2011 83
- Dietary supplements notified in Poland by Merck, 2010-February 2011 85
- Dietary supplements notified in Poland by NP Pharma, Natur Produkt Zdrovit and Kruger, 2010-February 2011 87
- Dietary supplements notified in Poland by Pfizer/Ferrosan, 2010-February 2011 89
- Dietary supplements notified in Poland by Maspex Wadowice and Polski Lek, 2010-February 2011 90
- Dietary supplements notified in Poland by Teva, 2010-February 2011 92
- Dietary supplements notified in Poland by US Pharmacia, 2010-2011 94
- Dietary supplements notified in Poland by Walmark, 2010-2011 96
- Nutrition claims and conditions for their use within the European Union, 2011 104
- Vitamin substances which may be used in the manufacture of dietary supplements in Poland, 2011 106
- Mineral substances which may be used in the manufacture of dietary supplements in Poland, 2011 107
- New chemicals forms approved for use in the production of dietary supplements in Poland, 2010 108
- Reference values for vitamins and minerals for the labelling on dietary supplements in Poland, 2010 in comparison with the previous value 108
- Basic macroeconomic indices for Poland, 2009-2010 115
- Largest Polish urban agglomerations by number of inhabitants, 2010 126
Dietary supplements market in Poland 2011
Development forecasts for 2011-2013
Choose your version of this product:
| Language / Licence | Single | 5 Users | Corporate | Global |
| English or Polish | 1800€ | 2700€ | 3600€ | 4500€ |
| English and Polish | 2520€ | 3780€ | 5040€ | 6300€ |
Compare licences
- - for the product preservation: saving the product in the memory of one computer belonging to the client;
- - for multiplying and making the product available: multiplication of the product by production of its copies either by printing or by digitalisation (e.g. on a disc, CD-ROM, DVD, magnetic tape, magneto-optic carrier, print and electronic devices, including electronic paper) for the individual use of one person only, who is indicated by the client during purchasing process.
Any other preservation, multiplication, copying and dissemination etc. which is beyond the scope of this licence is strictly forbidden.
- - for the product preservation: saving the product in the memory of 2 to 5 computers belonging to the organisation indicated by the client while purchasing process; these computers must be located in the same country as the organisation indicated during purchasing process;
- - for multiplying and making the product available: multiplication of the product by production of its copies either by printing or by digitalisation (e.g. on a disc, CD-ROM, DVD, magnetic tape, magneto-optic carrier, print and electronic devices, including electronic paper) for 2 to 5 people who work for the organisation indicated by the client during purchasing process, and who are in the same country as the organisation indicated during purchasing process.
Any other preservation, multiplication, copying and dissemination etc. which is beyond the scope of this licence is strictly forbidden.
- - for the product preservation: saving the product in the memory of an unlimited number of computers belonging to the organisation indicated by the client during purchasing process; these computers must be located in the same country as the organisation indicated during purchasing process;
- - for multiplying and making the product available: multiplication of the product by production of its copies either by printing or by digitalisation (e.g. on a disc, CD-ROM, DVD, magnetic tape, magneto-optic carrier, print and electronic devices, including electronic paper) for an unlimited number of people who work for the organisation indicated by the client during purchasing process, who are in the same country as the organisation indicated during purchasing process.
Any other preservation, multiplication, copying and dissemination etc. which is beyond the scope of this licence is strictly forbidden.
- - for the product preservation: saving the product in the memory of an unlimited number of computers belonging to the organisation indicated by the client during purchasing process; these computers can be located in or outside of the country of the organisation indicated during purchasing process;
- - for multiplying and making the product available: multiplication of the product by production of its copies either by printing or by digitalisation (e.g. on a disc, CD-ROM, DVD, magnetic tape, magneto-optic carrier, print and electronic devices, including electronic paper) for an unlimited number of people who work for the organisation indicated by the client during purchasing process, who are in or outside of the country of the organisation indicated during purchasing process.
Any other preservation, multiplication, copying and dissemination etc. which is beyond the scope of this licence is strictly forbidden.